Combination of Tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species

Curcumin (Cur) has been extensively studied in several types of malignancies including colorectal cancer (CRC); however its clinical application is greatly affected by low bioavailability. Several strategies to improve the therapeutic response of Cur are being pursued, including its combination with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankpal, Umesh T., Nagaraju, Ganji Purnachandra, Gottipolu, Sriharika R., Hurtado, Myrna, Jordan, Christopher G., Simecka, Jerry W., Shoji, Mamoru, El-Rayes, Bassel, Basha, Riyaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823099/
https://www.ncbi.nlm.nih.gov/pubmed/26672603
http://dx.doi.org/10.18632/oncotarget.6553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823099/
https://www.ncbi.nlm.nih.gov/pubmed/26672603
http://dx.doi.org/10.18632/oncotarget.6553

Ejemplares similares